ASPIRIN effervescent, 500 mg, effervescent tablets
Acidum acetylsalicylicum
important information for the patient.
This medicine should always be taken exactly as described in this package leaflet for the patient or as advised by your doctor or pharmacist.
Aspirin effervescent contains acetylsalicylic acid, which acts as a pain reliever, anti-inflammatory, and antipyretic.
Indications for use:
Before starting to take Aspirin effervescent, the patient should discuss it with their doctor or pharmacist:
Drugs containing acetylsalicylic acid should not be taken by women in the first and second trimester of pregnancy, unless it is absolutely necessary.
Acetylsalicylic acid may cause bronchospasm and trigger asthma attacks or other hypersensitivity reactions. Patients with asthma, chronic respiratory diseases, hay fever, nasal polyps, and those who experience allergic reactions to other substances (e.g., skin reactions, itching, hives) are particularly at risk.
Patients undergoing surgical procedures (including minor procedures, e.g., tooth extraction) should inform their doctor about taking Aspirin effervescent.
Acetylsalicylic acid, even in small doses, reduces the excretion of uric acid from the body. In patients with a tendency to reduced uric acid excretion, the drug may cause a gout attack.
In the course of some viral diseases, especially in the case of influenza A or B virus infection or chickenpox, mainly in children and adolescents, there is a risk of developing Reye's syndrome - a rare but life-threatening disease. Persistent vomiting during infection may indicate the development of Reye's syndrome, which requires immediate medical attention.
The risk of developing Reye's syndrome during viral infections may increase if acetylsalicylic acid is administered at the same time, although a causal link has not been proven.
For these reasons, in children under 12 years of age, drugs containing acetylsalicylic acid should not be taken, and in adolescents over 12 years of age, drugs containing acetylsalicylic acid can only be taken on a doctor's prescription.
Long-term administration of drugs containing acetylsalicylic acid may cause headaches that worsen with each subsequent dose.
Long-term administration of painkillers, especially those containing multiple active substances, may lead to severe kidney function disorders and kidney failure.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Special caution should be exercised when taking Aspirin effervescent with the following medicines, as acetylsalicylic acid enhances:
Aspirin effervescent can be taken with the above-mentioned medicines (except for methotrexate at doses of 15 mg per week or higher) only after consulting a doctor.
See section 3 of the package leaflet.
Warning! Alcohol may increase the risk of adverse reactions from the gastrointestinal tract, i.e., mucosal ulceration or bleeding.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Pregnancy
Aspirin effervescent should not be taken during the last 3 months of pregnancy, as it may harm the unborn child or cause complications during delivery. The drug may cause kidney and heart function disorders in the unborn child. It may also affect the patient's and child's tendency to bleed and cause delayed or prolonged delivery. Aspirin effervescent should not be taken during the first 6 months of pregnancy, unless it is absolutely necessary and has been prescribed by a doctor. If the patient requires treatment during this period or is trying to conceive, they should take the lowest possible dose for the shortest possible time. If Aspirin effervescent is taken for more than a few days from the 20th week of pregnancy, it may cause kidney function disorders in the unborn child, leading to a decrease in the amount of amniotic fluid surrounding the fetus (oligohydramnios) or narrowing of the arterial duct in the child's heart. If treatment is necessary for more than a few days, the doctor may recommend additional monitoring.
Breastfeeding
Acetylsalicylic acid passes into breast milk in small amounts.
Fertility
Aspirin effervescent belongs to a group of medicines that may adversely affect female fertility. This effect is temporary and disappears after the end of therapy.
The medicine does not affect the ability to drive and use machines.
One effervescent tablet contains 543 mg of sodium (the main component of common salt). This corresponds to 27% of the maximum recommended daily dose of sodium in the diet for adults. The maximum daily dose of this product is equivalent to 216% of the WHO-recommended maximum daily intake of sodium. This should be taken into account in patients with reduced kidney function and in patients controlling their sodium intake.
This medicine should always be taken exactly as described in the package leaflet for the patient or as advised by the doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.
The recommended dose of Aspirin effervescent is:
The effervescent tablets should be dissolved in a glass of water and the effervescent liquid drunk. Take after meals.
Acetylsalicylic acid poisoning can be caused by prolonged administration of the medicine (mild poisoning) or overdose (severe poisoning), which can be life-threatening, e.g., after accidental ingestion by children or the elderly.
Symptoms of mild poisoning are: dizziness (including vertigo), tinnitus, deafness, excessive sweating, nausea, and vomiting, headache, confusion (disorders of consciousness with disorientation, thinking, and speech disorders, delusions, hallucinations, anxiety, and psychomotor agitation), rapid breathing, deep breathing, and symptoms of respiratory alkalosis (spots before the eyes, fainting).
In the case of severe poisoning, the following may also occur: high fever, respiratory disorders (up to respiratory arrest and suffocation), cardiovascular disorders (from irregular heartbeat, low blood pressure to cardiac arrest), fluid and electrolyte loss (from dehydration, oliguria [reduced urine output below 400-500 ml in adults] to kidney failure), increased or decreased blood glucose levels (especially in children), ketoacidosis, gastrointestinal bleeding, coagulation disorders, neurological disorders manifesting as lethargy, confusion, and up to coma and convulsions.
In the event of an overdose, the patient should immediately consult a doctor or pharmacist, and in the case of severe poisoning, the patient should be taken to the hospital immediately.
Treatment of poisoning involves gastric lavage, administration of activated charcoal, and alkaline diuresis. In severe cases, forced alkaline diuresis, peritoneal dialysis, or hemodialysis may be necessary.
In the event of a missed dose and persistence of symptoms, the next dose of Aspirin effervescent should be taken. A double dose should not be taken to make up for the missed dose.
In case of any further doubts related to the use of this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Aspirin effervescent can cause side effects, although not everybody gets them.
Warning!
Gastrointestinal disorders:
stomach and abdominal pain, heartburn, nausea, vomiting, indigestion, gastrointestinal inflammation, potentially life-threatening gastrointestinal bleeding: overt (coffee grounds-like vomiting, black, tarry stools) or occult (bleeding occurs more frequently the higher the dose); stomach or duodenal ulcers, perforation, enteropathy (especially during long-term use).
Liver and bile duct disorders:
In rare cases, transient liver function disorders (increased aminotransferase activity) have been reported.
Nervous system disorders:
Dizziness and tinnitus, usually symptoms of overdose.
Blood and lymphatic system disorders:
Increased risk of bleeding, bleeding (postoperative, nasal, gingival, genitourinary), hematoma, prolonged bleeding time, prothrombin time, thrombocytopenia.
Consequences of bleeding may include iron deficiency anemia or post-hemorrhagic anemia, manifesting as asthenia, pallor, hypoperfusion, as well as abnormal laboratory test results.
Hemolysis and hemolytic anemia in patients with severe glucose-6-phosphate dehydrogenase deficiency.
Vascular disorders:
Cerebral hemorrhage (especially in patients with uncontrolled hypertension and/or concomitant use of other anticoagulant drugs) potentially life-threatening.
Renal and urinary disorders:
Kidney function disorders and severe kidney damage.
Immune system disorders:
Hypersensitivity reactions with clinical symptoms and abnormal laboratory test results, such as respiratory system disease, which worsens after taking acetylsalicylic acid, mild to moderate reactions involving the skin, respiratory system, cardiovascular system with symptoms such as rash, urticaria, edema (including angioedema), respiratory and cardiac disorders, rhinitis, nasal congestion, and very rarely severe reactions, including anaphylactic shock.
Respiratory disorders:
Asthma.
If any side effects occur, including those not listed in the package leaflet, the patient should inform their doctor, pharmacist, or nurse.
Side effects can be reported directly to the Department of Post-Marketing Surveillance of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
Store in a temperature below 25°C.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after the term "EXP:". The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
White, round effervescent tablets packaged in sachets. The pack contains 10, 12, or 24 effervescent tablets.
Marketing authorization holder:
Bayer Sp. z o.o.
Al. Jerozolimskie 158
02-326 Warsaw
Tel.: +48 22 572 35 00
Fax: +48 22 572 35 55
Manufacturer:
Bayer Bitterfeld GmbH
OT Greppin
Salegaster Chaussee 1
06803 Bitterfeld-Wolfen
Germany
Date of last revision of the package leaflet:08/2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.